

Dupilumab shifts the gut microbiome to a healthy state in patients with atopic dermatitis
In this medfyle
A significant reversal of skin microbial dysbiosis in AD has been observed after dupilumab, but little is known about the impact of this treatment on the gut flora – until now.
Presenting Author
About this Medfyle
This is a summary of a presentation given at the EADV Congress 2023. The content is developed by Infomedica in collaboration with the EADV.
The information and data provided is for information purposes only. The presenting author(s) of the original presentation had no involvement in the creation of this content. The viewpoints expressed may not represent Infomedica, or the EADV.
©2023 Infomedica. All rights reserved.